Acro Biomedical Co., Ltd. (ACBM) financial statements (2022 and earlier)

Company profile

Business Address 12175 VISIONARY WAY
FISHERS, IN 46038
State of Incorp. NV
Fiscal Year End December 31
SIC 79 - Amusement And Recreation Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1811373
Cash and cash equivalents 1811373
Inventory, net of allowances, customer advances and progress billings 9381,0601,147481 
Inventory 9381,0601,147481 
Prepaid expense 1333031 
Deposits current assets  5   
Other undisclosed current assets 16    
Total current assets: 9731,0691,4785483
Noncurrent Assets
Operating lease, right-of-use asset 25 
Other undisclosed noncurrent assets   5  
Total noncurrent assets: 25 5  
TOTAL ASSETS: 9981,0691,4835483
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2518717
Taxes payable   92  
Other undisclosed accounts payable and accrued liabilities 2518(85)17
Due to related parties 243621413610
Other undisclosed current liabilities 4511692  
Total current liabilities: 3121962413717
Noncurrent Liabilities
Total liabilities: 3121962413717
Stockholders' equity
Stockholders' equity attributable to parent 6868741,242511(15)
Common stock 4848484816
Additional paid in capital 87787186955861
Retained earnings (accumulated deficit) (239)(45)325(94)(92)
Total stockholders' equity: 6868741,242511(15)
TOTAL LIABILITIES AND EQUITY: 9981,0691,4835483

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Revenues 6881,3548,015510 
Cost of revenue (529)(1,219)(7,181)(459) 
Gross profit: 15913583351 
Operating expenses (290)(577)(318)(53)(43)
Other undisclosed operating income     87
Operating income (loss): (130)(442)516(2)43
Nonoperating expense (5)(2)(4)  
Interest and debt expense (5)(2)(4)  
Other undisclosed income from continuing operations before equity method investments, income taxes 524  
Income (loss) from continuing operations before income taxes: (136)(444)512(2)43
Income tax expense (benefit) 1873(92)  
Net income (loss): (117)(371)420(2)43
Other undisclosed net loss attributable to parent     (87)
Net income (loss) available to common stockholders, diluted: (117)(371)420(2)(43)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
9/30/2019
9/30/2018
9/30/2017
9/30/2016
Net income (loss): (117)(371)420(2)43
Comprehensive income (loss), net of tax, attributable to parent: (117)(371)420(2)43

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: